Read More

FMC Corporation Response To Inaccurate Short-Seller Report; Says ‘Blue Orca Capital Made Misleading And Factually Inaccurate Statements Regarding FMC’s Patents For Its Diamide Insecticide Technology And Inaccurately Speculated On The Strength Of The Co…

FMC Corporation (NYSE: FMC) announced that the report published today by short-seller Blue Orca Capital made misleading and factually inaccurate statements regarding FMC's patents for its diamide insecticide technology and inaccurately speculated on the strength of FMC's business.

FMC

Read More

CRISPR Therapeutics Announces Leadership Transition; Co-Founder, Rodger Novak, M.D., To Step Down As President And Chairman; CEO Samarth Kulkarni, Ph.D., To Succeed Dr. Novak As Chairman Effective September 15, 2023

-CRISPR Therapeutics co-founder, Rodger Novak, M.D., to step down as President and Chairman, effective September 15, 2023- -Samarth Kulkarni, Ph.D., to succeed Dr. Novak as Chairman and will continue serving as CEO of

CRSP